Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 8, 2018

Primary Completion Date

March 6, 2025

Study Completion Date

March 31, 2026

Conditions
Fanconi AnemiaSquamous Cell Carcinoma
Interventions
DRUG

Quercetin (dietary supplement)

Quercetin will be administered twice daily at an adjusted dose based on weight for a maximum total daily dose of 4000mg/day. If the patient is 70 kg or more, the dose will automatically be assigned at the maximum dose of 4000mg/day.

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER